Drug pricing probed
Article Abstract:
Drug manufacturers are under investigation by the federal government for overpricing. The Justice Department is investigating pricing practices that could be costing taxpayers over $1 billion a year. The investigation is focusing on the practice of drug companies to set wholesale prices high so that physicians and other healthcare providers can bill Medicare and Medicaid higher than what the providers are actually paying for.
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Drug spending soars 84% in last five years
Article Abstract:
Prescription drug spending soared 84% from 1993 to 1998, according to a study prepared for the research group National Institute for Health Care Management. The increase was prompted by higher drug prices, which accounted for 64% of the total gain in medication expenditures from 1993 to 1998, as well as raised demand for heavily advertised pharmaceuticals. The report also revealed that insurance companies and employers bore most of the increase in expenditures.
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Diet drug maker settles for $4.8 billion
Article Abstract:
American Home Products agreed to pay $4.8 billion to consumers who may suffer heart damage from its weight-loss combination drugs called 'fen- phen.' Some 5.8 million dieters used the drugs. The popular diet drugs were taken off the market after studies indicated that they caused heart valve damage. The agreement includes $1 billion for medical tests, $2.3 billion for damages to those suffering from or will later develop heart problems and $429 million for legal costs.
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Noranda sells 4% stake in gold miner Newmont to U.S. dealer for $246-million. Noranda acquires stake in Rio Algom
- Abstracts: Microsoft findings spur lawsuit filings. Microsoft CEO plays to win. Microsoft's Gates steps aside as CEO
- Abstracts: Dow's fall seen as chance to `selectively buy'. Blue chips push higher; techs fall again. Earnings warnings likely to continue
- Abstracts: Tire concerns go back 1 1/2 years before recall. GM may declare end of the road for Prizm. Fuel efficient cars on way - someday
- Abstracts: Judge's decision could trigger breakup of giant. Questions haunt Microsoft's future. Microsoft set sights on tablet PC, basics